The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Parkinson Disease, Essential Tremor, Dystonia
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
-
St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States, 85013
University of California, San Francisco, San Francisco, California, United States, 94143
University of Miami Hospital, Miami, Florida, United States, 33136
University of South Florida, Tampa, Florida, United States, 33612
St. Luke's Regional Medical Center, Boise, Idaho, United States, 83712
Albany Medical Center, Albany, New York, United States, 12208
Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States, 27157
Allegheny General Hospital, Pittsburgh, Pennsylvania, United States, 15212
Swedish Neuroscience Institute, Seattle, Washington, United States, 98122
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
to
ALL
No
Boston Scientific Corporation,
Natalie Bloom Lyons, STUDY_DIRECTOR, Boston Scientific Neuromodulation Corporation
2028-12